Author

David Goldstein

University Health Network

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Abilasha Rao‐BhatiaiD· 1 shared Alison E. Casey· 1 shared Amanda KhooiD· 1 shared Amber Johns· 1 shared Andrew D Campbell· 1 shared Angela Chou· 1 shared Anouschka Akerman· 1 shared Anthony Gill· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abilasha Rao‐BhatiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers

Meinusha Govindarajan, Salvador Mejia‐Guerrero, Shawn C. Chafe, Shahbaz Khan, Wei Shi, Matthew Waas, Martín A. Rossotti, Amanda Khoo, Lydia Liu, Vladimir Ignatchenko, Simona Principe, Lusia Sepiashvili, Greg Hussack, Nazanin Tatari, Chitra Venugopal, , Thomas Kislinger

This paper uses N-glycoproteomics to analyze patient-derived xenografts, identifies FAT2 as a therapeutic target for head and neck cancers, and validates its role in tumor growth and CAR T cell activity.

Cell Reports Medicine · Jan 23, 2026Peer-reviewedCancer Biology

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition

George Sharbeen, Joshua A McCarroll, Anouschka Akerman, Chantal Kopecky, Janet Youkhana, Jeff Holst, Cyrille Boyer, Mert Erkan, David Goldstein, Paul Timpson, Thomas R Cox, Brooke A Pereira, Jessica L Chitty, Sigrid Fey, Arafath K Najumudeen, , Phoebe A Phillips

This study shows that SLC7A11 in pancreatic ductal adenocarcinoma stroma, not tumor cells, predicts poor survival and that inhibiting it reduces CAF activity and tumor growth.

bioRxiv · Jul 12, 2020Cancer Biology